Literature DB >> 27444232

Communicating information concerning potential medication harms and benefits: What gist do numbers convey?

Susan J Blalock1, Adam Sage2, Michael Bitonti3, Payal Patel3, Rebecca Dickinson4, Peter Knapp5.   

Abstract

OBJECTIVES: Fuzzy trace theory was used to examine the effect of information concerning medication benefits and side-effects on willingness to use a hypothetical medication.
METHODS: Participants (N=999) were recruited via Amazon Mechanical Turk. Using 3×5 experimental research design, each participant viewed information about medication side effects in 1 of 3 formats and information about medication benefits in 1 of 5 formats. For both side-effects and benefits, one format presented only non-numeric information and the remaining formats presented numeric information.
RESULTS: Individuals in the non-numeric side-effect condition were less likely to take the medication than those in the numeric conditions (p<0.0001). In contrast, individuals in the non-numeric benefit condition were more likely to take the medication than those in the numeric conditions (p<0.0001).
CONCLUSIONS: Our findings suggest that non-numeric side-effect information conveys the gist that the medication can cause harm, decreasing willingness to use the medication; whereas non-numeric benefit information has the opposite effect. PRACTICE IMPLICATIONS: Presenting side-effect and benefit information in non-numeric format appears to bias decision-making in opposite directions. Providing numeric information for both benefits and side-effects may enhance decision-making. However, providing numeric benefit information may decrease adherence, creating ethical dilemmas for providers.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fuzzy trace theory; Gist; Medications; Risk communication

Mesh:

Year:  2016        PMID: 27444232     DOI: 10.1016/j.pec.2016.07.022

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  6 in total

1.  The Unintended Consequences of Adverse Event Information on Medicines' Risks and Label Content.

Authors:  Giovanni Furlan; David Power
Journal:  Pharmaceut Med       Date:  2020-11-16

2.  Development, piloting, and evaluation of an evidence-based informed consent form for total knee arthroplasty (EvAb-Pilot): a protocol for a mixed methods study.

Authors:  Alina Weise; Julia Lühnen; Stefanie Bühn; Felicia Steffen; Sandro Zacher; Julia Lauberger; Deha Murat Ates; Andreas Böhmer; Henning Rosenau; Anke Steckelberg; Tim Mathes
Journal:  Pilot Feasibility Stud       Date:  2021-05-13

3.  Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study.

Authors:  Ahmad A Sherbini; James M Gwinnutt; Kimme L Hyrich; Suzanne M M Verstappen
Journal:  Rheumatology (Oxford)       Date:  2022-10-06       Impact factor: 7.046

4.  Communicating risk of medication side-effects: role of communication format on risk perception.

Authors:  Ruta Sawant; Sujit Sansgiry
Journal:  Pharm Pract (Granada)       Date:  2018-06-27

Review 5.  A systematic review of factors associated with side-effect expectations from medical interventions.

Authors:  Louise E Smith; Rebecca K Webster; G James Rubin
Journal:  Health Expect       Date:  2020-04-13       Impact factor: 3.377

6.  Communicating Uncertainty in Written Consumer Health Information to the Public: Parallel-Group, Web-Based Randomized Controlled Trial.

Authors:  Roland B Büchter; Cornelia Betsch; Martina Ehrlich; Dennis Fechtelpeter; Ulrich Grouven; Sabine Keller; Regina Meuer; Constanze Rossmann; Andreas Waltering
Journal:  J Med Internet Res       Date:  2020-08-10       Impact factor: 5.428

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.